Kheria Autocomp IPO GMP

Listed

Kheria Autocomp IPO GMP & Listing Price

SME · ₹101 · 1200 shares/lot · NSE SME

Final GMP before listing
₹3+3.0%
24 Sept, 3:37 pm
IST

Range so far: ₹3 low · ₹10 high

16 Sept24 Sept
Listed at
₹104.9
Listing gain / lot
+₹4,680
Cost / lot
₹1,21,200

GMP vs actual listing

GMP implied
+3.0%
Listed at
₹104.9
Actual
+3.9%

Closed its first day at ₹103.05 (+2.0% on the issue price)

Kheria Autocomp carried a grey market premium of ₹3 on an issue price of ₹101, implying a listing around ₹104 (+3.0%). It opened at ₹104.9, +3.9% — almost exactly what the grey market implied.

The premium shown is the one published here before listing, frozen at the bell and never revised afterwards. See all 208 calls, including the misses.

Timeline

  1. Opens
    17 Sept
  2. Closes
    21 Sept
  3. Allotment
    22 Sept
  4. Listing
    24 Sept

Subscription status

as of 24 Sept, 3:37 pm
Total2.48x
Issue typeSME
Incorporated2009
SectorAuto Components & Equipments
Price₹101
Lot size1200 shares
Min investment₹1,21,200
Issue size₹46.44 Cr
P/E ratio9.95
Face value₹10
RegistrarKFin Technologies
ISININE0HOL01013
Listing atNSE SME
Listing dateThu, 24 Sept, 2026
NSE symbolKHERIAAUTO
BSE code216626

Official documents

Kheria Autocomp IPO FAQs

What was the listing price of Kheria Autocomp IPO?

Kheria Autocomp IPO listed at ₹104.9 on Thu, 24 Sept, 2026, +3.9% against the issue price of ₹101, a gain of ₹4,680 on one lot of 1200 shares. The last grey market premium before listing was ₹3, which implied ₹104.

What was the GMP of Kheria Autocomp IPO before listing?

The last grey market premium for Kheria Autocomp IPO was ₹3, recorded at 3:37 pm IST on Thu, 24 Sept, 2026. That implied +3.0% over the ₹101 price. The stock actually listed +3.9%, so GMP was off by 0.9%.

When was Kheria Autocomp IPO allotment and listing?

Allotment for Kheria Autocomp IPO was finalised on Tue, 22 Sept, 2026 and the shares listed on Thu, 24 Sept, 2026 on NSE SME. The registrar is KFin Technologies.

GMP is unofficial. Grey market premium is an unregulated, over-the-counter indication with no backing from SEBI, BSE or NSE. It is not a listing-price guarantee and not investment advice. Read the RHP and consult a SEBI-registered adviser before applying.